These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 39295845)

  • 21. Bladder tumor markers: a review of the literature.
    Volpe A; Racioppi M; D'Agostino D; Cappa E; Gardi M; Totaro A; Pinto F; Sacco E; Marangi F; Palermo G; Bassi PF
    Int J Biol Markers; 2008; 23(4):249-61. PubMed ID: 19199274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel urinary biomarkers for the detection of bladder cancer: A systematic review.
    Tan WS; Tan WP; Tan MY; Khetrapal P; Dong L; deWinter P; Feber A; Kelly JD
    Cancer Treat Rev; 2018 Sep; 69():39-52. PubMed ID: 29902678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer.
    D'Andrea D; Soria F; Zehetmayer S; Gust KM; Korn S; Witjes JA; Shariat SF
    BJU Int; 2019 Jun; 123(6):959-967. PubMed ID: 30653818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular markers in disease detection and follow-up of patients with non-muscle invasive bladder cancer.
    Maas M; Walz S; Stühler V; Aufderklamm S; Rausch S; Bedke J; Stenzl A; Todenhöfer T
    Expert Rev Mol Diagn; 2018 May; 18(5):443-455. PubMed ID: 29707982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary extracellular vesicles-encapsulated miRNA signatures: A new paradigm for urinary bladder cancer diagnosis and classification.
    Kural S; Jain G; Agarwal S; Das P; Kumar L
    Urol Oncol; 2024 Jul; 42(7):179-190. PubMed ID: 38594151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical performance and utility of a noninvasive urine-based methylation biomarker: TWIST1/Vimentin to detect urothelial carcinoma of the bladder.
    Zhang C; Xu X; Wang T; Lu Y; Lu Z; Wang T; Pan Z
    Sci Rep; 2024 Apr; 14(1):7941. PubMed ID: 38575639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-invasive diagnosis and surveillance of bladder cancer with driver and passenger DNA methylation in a prospective cohort study.
    Xiao Y; Ju L; Qian K; Jin W; Wang G; Zhao Y; Jiang W; Liu N; Wu K; Peng M; Cao R; Li S; Shi H; Gong Y; Zheng H; Liu T; Luo Y; Ma H; Chang L; Li G; Cao X; Tian Y; Xu Z; Yang Z; Shan L; Guo Z; Yao D; Zhou X; Chen X; Guo Z; Liu D; Xu S; Ji C; Yu F; Hong X; Luo J; Cao H; Zhang Y; Wang X
    Clin Transl Med; 2022 Aug; 12(8):e1008. PubMed ID: 35968916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From Detection to Cure - Emerging Roles for Urinary Tumor DNA (utDNA) in Bladder Cancer.
    Linscott JA; Miyagi H; Murthy PB; Yao S; Grass GD; Vosoughi A; Xu H; Wang X; Yu X; Yu A; Zemp L; Gilbert SM; Poch MA; Sexton WJ; Spiess PE; Li R
    Curr Oncol Rep; 2024 Aug; 26(8):945-958. PubMed ID: 38837106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Cell-Debris and Room-Temperature Storage on Urine Circulating Tumor DNA from Hepatocellular Carcinoma.
    Kim AK; Lin SY; Wang Z; Luu H; Hamilton JP; Song W; Su YH
    J Mol Diagn; 2023 Dec; 25(12):913-920. PubMed ID: 37813297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary glycoprotein biomarker discovery for bladder cancer detection using LC/MS-MS and label-free quantification.
    Yang N; Feng S; Shedden K; Xie X; Liu Y; Rosser CJ; Lubman DM; Goodison S
    Clin Cancer Res; 2011 May; 17(10):3349-59. PubMed ID: 21459797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-throughput molecular analysis of urine sediment for the detection of bladder cancer by high-density single-nucleotide polymorphism array.
    Hoque MO; Lee J; Begum S; Yamashita K; Engles JM; Schoenberg M; Westra WH; Sidransky D
    Cancer Res; 2003 Sep; 63(18):5723-6. PubMed ID: 14522891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer.
    Roperch JP; Grandchamp B; Desgrandchamps F; Mongiat-Artus P; Ravery V; Ouzaid I; Roupret M; Phe V; Ciofu C; Tubach F; Cussenot O; Incitti R
    BMC Cancer; 2016 Sep; 16(1):704. PubMed ID: 27586786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary Biomarkers in Tumors: An Overview.
    Cimmino I; Bravaccini S; Cerchione C
    Methods Mol Biol; 2021; 2292():3-15. PubMed ID: 33651347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study.
    Chauhan PS; Chen K; Babbra RK; Feng W; Pejovic N; Nallicheri A; Harris PK; Dienstbach K; Atkocius A; Maguire L; Qaium F; Szymanski JJ; Baumann BC; Ding L; Cao D; Reimers MA; Kim EH; Smith ZL; Arora VK; Chaudhuri AA
    PLoS Med; 2021 Aug; 18(8):e1003732. PubMed ID: 34464379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.
    Urakami S; Shiina H; Enokida H; Kawakami T; Kawamoto K; Hirata H; Tanaka Y; Kikuno N; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2109-16. PubMed ID: 16609023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers.
    Lopez-Beltran A; Cheng L; Gevaert T; Blanca A; Cimadamore A; Santoni M; Massari F; Scarpelli M; Raspollini MR; Montironi R
    Expert Rev Mol Diagn; 2020 Feb; 20(2):231-243. PubMed ID: 31795775
    [No Abstract]   [Full Text] [Related]  

  • 37. Diagnostic Test Accuracy of Urinary DNA Methylation-based Biomarkers for the Detection of Primary and Recurrent Bladder Cancer: A Systematic Review and Meta-analysis.
    Silva-Ferreira M; Carvalho JA; Salta S; Henriques TS; Pereira Rodrigues P; Monteiro-Reis S; Henrique R; Jerónimo C
    Eur Urol Focus; 2024 Jun; ():. PubMed ID: 38897871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel and sensitive DNA methylation marker for the urine-based liquid biopsies to detect bladder cancer.
    Deng L; Chao H; Deng H; Yu Z; Zhao R; Huang L; Gong Y; Zhu Y; Wang Q; Li F; Liu L; He L; Tang Z; Liao C; Qi Y; Wang X; Zeng T; Zou H
    BMC Cancer; 2022 May; 22(1):510. PubMed ID: 35524222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current bladder tumor tests: does their projected utility fulfill clinical necessity?
    Lokeshwar VB; Soloway MS
    J Urol; 2001 Apr; 165(4):1067-77. PubMed ID: 11257640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of Apo-A1 as a potential bladder cancer biomarker by urine proteomics and analysis.
    Li C; Li H; Zhang T; Li J; Liu L; Chang J
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1047-52. PubMed ID: 24661883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.